Whitney Notaro | Vice President, Investor Relations |
Doug Hirsch | Co-Founder & Co-Chief Executive Officer |
Trevor Bezdek | Co-Founder Co-Chief Executive Officer, |
Karsten Voermann | Chief Financial Officer |
Justin Post | Bank of America |
John Ransom | Raymond James |
Mark Mahaney | Evercore |
George Hill | Deutsche Bank |
Sean Dodge | RBC Capital Markets |
Sandy Draper | Guggenheim |
Charles Rhyee | Cowen |
Ricky Goldwasser | Morgan Stanley |
Glen Santangelo | Jefferies |
Stephanie Davis | SVB |
Doug Anmuth | JPMorgan |
Steven Valiquette | Barclays |
Jonathan Yong | Credit Suisse |
Stan Berenshteyn | Wells Fargo |
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx First Quarter 2022 Earnings Call. At this time -- as a reminder, today's conference call is being recorded. I would now like to introduce your host for today's call, Whitney Notaro, Vice President of Investor Relations. Ms. Notaro, you may begin.